Rankings
▼
Calendar
XOMAP Q3 2019 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
+888.3% YoY
Gross Profit
$9M
98.4% margin
Operating Income
$3M
32.6% margin
Net Income
$3M
35.9% margin
EPS (Diluted)
$0.28
QoQ Revenue Growth
+820.5%
Cash Flow
Operating Cash Flow
$4M
Free Cash Flow
-$9M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$86M
Total Liabilities
$60M
Stockholders' Equity
$26M
Cash & Equivalents
$40M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$896,000
+888.3%
Gross Profit
$9M
$259,000
+3263.7%
Operating Income
$3M
-$5M
+154.5%
Net Income
$3M
-$5M
+169.4%
← FY 2019
All Quarters
Q4 2019 →